Oncocyte target price wsj
Web06. apr 2024. · MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available … WebAt Oncocyte, we focus on tomorrow to help deliver better patient care today. Products Diagnostics for peace of mind Our mission is to develop a family of tests to provide physicians and their patients actionable answers at critical decision points across the patient care continuum.
Oncocyte target price wsj
Did you know?
Web05. apr 2024. · OncoCyte has a 1-year low of $0.20 and a 1-year high of $1.58. The company has a market capitalization of $34.42 million, a price-to-earnings ratio of -0.45 and a beta of 1.62. The stock’s 50...
Web18. mar 2024. · The average twelve-month price prediction for CyrusOne is $90.50 with a high price target of $90.50 and a low price target of $90.50. Do Wall Street analysts like CyrusOne more than its competitors? Analysts like … WebOCX Oncocyte Corp. Stock Price & News - WSJ Subscribe Sign In Oncocyte Corp. OCX (U.S.: Nasdaq) View All companies AT CLOSE 4:00 PM EDT 03/31/23 $0.3544 USD …
Web05. feb 2024. · Oncocyte Announces Pricing of $35 Million Public Offering of Common Stock February 05, 2024 08:25 ET Source: Oncocyte Corporation Oncocyte Corporation Web05. apr 2024. · Price target increased to US$8.67 Mar 18 OncoCyte Corporation Announces Peer-Reviewed Publication of Data Assessing Use of DetermaIO™ to …
WebONCY Oncolytics Biotech Inc. Analyst Estimates & Rating – WSJ Oncolytics Biotech Inc. ONCY (U.S.: Nasdaq) View All companies AT CLOSE 4:00 PM EDT 03/21/23 $1.27 …
Web10. apr 2024. · 89,3%. More Financials. Company. OncoCyte Corporation is a molecular diagnostics company. The Company is focused on developing and commercializing … et18 pro ドキュメントスキャナーWebOCX Oncocyte Corp. Analyst Estimates & Rating – WSJ Oncocyte Corp. OCX (U.S.: Nasdaq) View All companies AT CLOSE 4:00 PM EDT 03/28/23 $0.29 USD 0.012 4.32% AFTER HOURS 7:17 PM EDT 03/28/23... Oncocyte Corp. analyst ratings, historical stock prices, earnings estimates & … et122系 nゲージWebIRVINE, Calif., March 31, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, today announced plans to file a Form 12b-25 … et1980 グレーWebOncoCyte (OCX) Stock Forecast & Price Target 387 Followers See the Price Targets and Ratings of: All Analysts Top Analysts Premium OCX Analyst Ratings Currently, no data available Based on 0 analysts giving stock ratings to OncoCyte in the past 3 months OCX Stock 12 Months Forecast There Are No Analyst Ratings for OCX In The Last 3 Months. et127系 nゲージWeb12. apr 2024. · 4 brokerages have issued twelve-month target prices for OncoCyte's shares. Their OCX share price forecasts range from $0.45 to $3.00. On average, they predict the … et 2022 パシフィコWeb06. apr 2024. · On average, analysts give OCX a Buy rating. The average price target is $1.36, which means analysts expect the stock to add by 338.71% over the next twelve months. That average ranking earns OCX an Analyst Rating of 24, which is better than 24% of stocks based on data compiled by InvestorsObserver . Wall Street analysts are rating … et-1t ジョイフルWeb12. apr 2024. · Consensus Analyst Rating Moderate Buy Based on 11 Analyst Ratings Consensus Analyst Price Target $17.52 94.46% Upside Get NIO Upgrade and Downgrade Alerts Sign-up to receive the latest news and ratings for NIO and its competitors with MarketBeat's FREE daily newsletter. NIO Analyst Ratings By Month NIO Price Targets … et2100 ブルーレイディスクドライブ